NCT07836699

Effect of Trimetazidine on Coronary Flow in Transthyretin Cardiac Amyloidosis

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2027-01Est. Completion: 2027-08-01

Enrollment target: 20 participants

Locations

Instituto do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil

Contact

Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a heart condition caused by a protein called transthyretin (TTR) build…

Innsbruck, AustriaEst. completion Apr 15, 2028

Amyloidogenic Transthyretin (ATTR) AmyloidosisCardiac Amyloidosis

The goal of this study is to learn whether PET-CT imaging using evuzamitide can help diagnose transthyretin cardiac amyl…

Boston, United StatesEst. completion Mar 15, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.